Thursday, 16 October, 2025
Graph AI Secures $3 Million Seed Funding to Revolutionize Pharmacovigilance
Graph AI, a California-based AI life sciences startup, has raised $3 million in seed funding led by Bessemer Venture Partners. Founded in 2024, the company aims to transform pharmacovigilance by addressing inefficiencies in traditional drug safety monitoring. Its flagship platform, Graph Safety, automates critical processes such as adverse drug event case processing, signal detection, and regulatory reporting, leading to significant efficiency gains and cost reductions for enterprise customers.
Read full story at Economic Times